cardiovascular-agents has been researched along with rofecoxib* in 1 studies
1 other study(ies) available for cardiovascular-agents and rofecoxib
Article | Year |
---|---|
Viewpoint: an explanation for the cardiovascular effects of bevacizumab and rofecoxib?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Cardiovascular Agents; Cardiovascular System; Cyclooxygenase 2; Humans; Lactones; Sulfones; Vascular Endothelial Growth Factor A | 2006 |